Collaborative Innovation - The Results are in..

The top 5 collaborative innovators in biopharma are.....
Let’s begin with the fact that several companies consistently rank “top of the pops.” Three of the five companies with which biotech executives most want to partner this year – Roche, Genentech and Lilly – have featured high on the list since 2006, while a fourth – GlaxoSmithKline – has done so since 2008.

Moreover, these companies are not simply good at handling one aspect of biopartnering, be it deal sourcing, formation or management; on the contrary, they stand out in most other ways (see Figure 4). Roche has ranked among the top five companies in all but one category in one year. Lilly, GlaxoSmithKline and Genentech have also regularly appeared in the top five rankings, although Genentech has lately slipped down the ladder. It figures among this year’s most highly rated partners primarily because of its high ranking across other individual partnership drivers that were measured. These include its reputation for innovativeness, the caliber of its people and its strong commitment to partnering at senior management level.

The key question is what are these companies doing to lead the pack? To answer that question you should download the full report from this link

If your company wasn't in the top five and you want to know where you placed in this study then contact me at sthender@us.ibm.com and I will be happy to share the more detailed results with you.